Key facts
- This page summarizes Hoedt Rob Ten's Form 4 filing for Medtronic plc (MDT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Aug 2023, 20:21.
Hoedt Rob Ten - 03 Aug 2023 Form 4 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- EVP and Pres. Global Regions
- Issuer ticker
- MDT
- Reported as of
- 03 Aug 2023
- Net transaction value
- -$342,269
- SEC form
- 4
- Accepted by SEC
- 07 Aug 2023, 20:21:49 UTC
- Prior SEC filing
- 02 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas L. Osteraas, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Hoedt Rob Ten filed Form 4 for Medtronic plc (MDT) on 07 Aug 2023.
Change
- Previous filing in this sequence was filed on 02 Aug 2023.
- Current net transaction value: -$342,269.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +4,251
- Change %
- +8.1%
- Price
- $0.000000
- Shares after
- 56,799
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2
MDT
transaction
Ordinary Shares
Tax liability
- Transaction value
- $342,269
- Shares
- -4,051
- Change %
- -7.1%
- Price
- $84.49
- Shares after
- 52,748
- Date
- 03 Aug 2023
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDT
transaction
Derivative
Performance Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,251
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 03 Aug 2023
- Ownership
- Direct
- Underlying class
- Performance Share Unit
- Underlying amount
- 4,251
- Exercise price
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.
Footnote F2
Includes 49 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.
Footnote F3
Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.
Footnote F4
Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
Footnote F5
The performance share units vested on August 3, 2023.